Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12194078
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
granted -
US 12195804
Treatment of squamous cell carcinoma
granted -
US 12186368
Compositions and methods for treatment of protease mediated disease
granted -
US 12186406
Materials and methods for treatment of hereditary haemochromatosis
granted -
US 12186306
Methods of treatment for cystic fibrosis
granted -
US 12186285
Compositions and methods of treatment for tinea pedis
granted -
US 12186349
Compositions and methods for C. difficile treatment
granted -
US 12186314
Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia
granted -
US 12186282
Treatment of 22Q11.2 deletion syndrome with cannabidiol
granted -
US 12178848
Methods and compositions for the treatment of exocrine pancreatic insufficiency
granted -
US 12180471
Antisense oligonucleotides for the treatment of Stargardt disease
granted -
US 12173058
Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
granted -
US 12171786
Use of mesenchymal stem cells for the treatment of inflammation
granted -
US 12171765
Combination therapies using PRMT5 inhibitors for the treatment of cancer
granted -
US 12173061
Compositions and methods for treatment of chronic lung diseases
granted -
US 12172969
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
granted -
US 12173306
Codon-optimized reduced-size ATP7A CDNA and uses for treatment of copper transport disorders
granted -
US 12161755
Sustained release device for treatment of Parkinson's disease and other disorders
granted -
US 12162821
Treatment of cataplexy
granted -
US 12162855
Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
granted -
US 12161607
Combination of cannabinoids in the treatment of leukemia
granted -
US 12157891
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
granted -
US 12156862
Medicaments for the treatment of vasoconstriction related diseases or disorders
granted -
US 2024390332
Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
granted